1. Pink Sheet
  2. >>Geography

Mexican, Turkish And Iranian Inspectors Become Latest Members Of PIC/S

 
• By Neena Brizmohun

Mexico, Turkey and Iran will start participating in the international Pharmaceutical Inspection Cooperation Scheme as of January 2018. Meanwhile, Russia has become the latest country to apply to join the scheme.

Capsule
More countries have joined the PIC/S • Source: Shutterstock

Drug regulators from Mexico, Turkey and Iran are to become the newest members of the Pharmaceutical Inspection Cooperation Scheme (PIC/S), which currently involves 49 authorities from 46 countries working to harmonize manufacturing inspection procedures worldwide.

Mexico’s agency COFEPRIS, the Turkish Medicines and Medical Devices Agency and Iran’s Food and Drug Administration will start to participate

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from International

More from Geography

Trump Administration Push For Dismissal, Transfer Of Mifepristone Case Leaves Overhang For Pharma

 
• By Sarah Karlin-Smith

The Trump Administration requested a dismissal or transfer of a lawsuit seeking to tighten the safety requirements for the abortion pill mifepristone on procedural grounds, which still leaves the administration's position on the case's merits unclear.

Opioid Safety: US FDA Hears Mixed Messages On Adding Posmarketing Studies To Labeling

 
• By Sue Sutter

Some advisory committee members said adding quantitative data on misuse, abuse, opioid use disorder and overdose to labeling would be helpful, but others worried the two epidemiological studies were not sufficiently generalizable to a broader population.

Viatris Agrees To $335m Opioid Settlement Ending US State, Local Government Cases

 
• By Dean Rudge

Viatris joined Hikma and Amneal, in signing agreements for cash settlements that resolve allegations its practices fueled the US’ deadly opioid epidemic.